NITI Aayog to release policy on integrative medicine, white paper on manufacturing Medical Devices

The think tank was mandated to prepare a policy paper on integrative medicine and a committee was constituted for developing an integrative health policy paper.

490
NITI Aayog
NITI Aayog

Last Updated on January 6, 2024 by The Health Master

NITI Aayog, the premier policy think tank of the government of India, is expected to soon come out with policy recommendations on integrative medicine, aiming to bring best practices of modern medicine and Ayush systems of medicine together.

It is also expected to release a white paper on promotion of domestic manufacturing of medical devices in the country.

The think tank was mandated to prepare a policy paper on integrative medicine and a committee was constituted for developing an integrative health policy paper.

So far, seven meetings have been held and the committee constituted four working groups, with more than 50 experts across the country, to provide deeper insights and recommendations in the areas of education, research, clinical practice and public health and administration.

“All four groups have submitted their reports. The task of synthesising the recommendations of the reports and finalising the draft is in progress,” said NITI Aayog.

The Integrative Health Policy aims to bring best practices of modern medicine and Ayush (Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa Rigpa and Homoeopathy) systems together to provide comprehensive healthcare to an individual and the community.

It has also recommended comprehensive regulatory overhauls, review of the existing taxation structure, a calibrated customs duty, extended coverage of the production-linked incentive scheme, strengthening the research and innovation ecosystem as some of the measures that can potentially favour the promotion of domestic manufacturing of medical devices, in a White Paper on promoting domestic manufacturing of medical devices, yet to be released to the public.

The paper analyses various scenarios for the manufacturing of different medical technologies and makes recommendations to augment and strengthen production in each scenario. The report is nearly finalized and will soon be released, it added.

The Department of Pharmaceuticals is expected to take the recommendations of a high level committee, formed to finalise a policy on research and development (R&D) and innovation in the pharmaceuticals and medical devices sectors, forward.

The high-level committee—comprising senior representatives of NITI Aayog and other Central ministries, along with industry captains—was constituted in May 2020, and NITI Aayog contributed to the formulation of the sections on ‘industry-academia linkage’, ‘regulatory enablement’, and ‘governance and infrastructure’ in the draft policy report.

NITI Aayog has also carried out a study on the status of emergency and injury care in the country, in collaboration with the Department of Emergency Medicine, JPNATC, AIIMS, New Delhi.

The consequent report assesses the prevailing status of 100 emergency and injury care centres in Government and private hospitals in 28 States and two Union Territories, in addition to 34 District hospitals and highlights the spectrum and load of emergency cases and exposes the prevailing gaps in ambulance services, health infrastructure, human resources and equipment in the provision of optimal care.

“The outcomes of this study will provide policy inputs to improve and strengthen emergency care services at all tiers of healthcare facilities in India,” said the think tank in its Annual Report for the year 2021-22.

Govt joins hands with industry to set up Pharma Park

Mandatory QR codes on APIs: Benefit or burden?

USFDA gives nod to Alembic Pharmaceuticals for anti fungal drug

Govt amends rules to allow import license for Medical Devices: Read

IPC flags safety alert against Blood Pressure drug, Losartan

USFDA gives nod to Aleor for Nystatin and Triamcinolone Acetonide Ointment

ICMR in collaboration with pharma companies to develop Dengue vaccine

DCGI gives nod to Zydus Oxemia to treat anaemia

Pfizer recalls this BP drug on potential cancer-causing impurity

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news